JP2007531594A - 薬剤を溶出する生体埋め込み型装置及び薬剤調製ポリマーシステム - Google Patents
薬剤を溶出する生体埋め込み型装置及び薬剤調製ポリマーシステム Download PDFInfo
- Publication number
- JP2007531594A JP2007531594A JP2007506531A JP2007506531A JP2007531594A JP 2007531594 A JP2007531594 A JP 2007531594A JP 2007506531 A JP2007506531 A JP 2007506531A JP 2007506531 A JP2007506531 A JP 2007506531A JP 2007531594 A JP2007531594 A JP 2007531594A
- Authority
- JP
- Japan
- Prior art keywords
- polyether urethane
- therapeutic agent
- loaded
- graft
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 199
- 229940079593 drug Drugs 0.000 title claims description 125
- 229920000642 polymer Polymers 0.000 title claims description 86
- 229940124597 therapeutic agent Drugs 0.000 claims abstract description 73
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000000654 additive Substances 0.000 claims abstract description 14
- 230000000996 additive effect Effects 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 60
- 229920000570 polyether Polymers 0.000 claims description 60
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 59
- 239000007943 implant Substances 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 42
- 239000002904 solvent Substances 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 32
- 230000009885 systemic effect Effects 0.000 claims description 32
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 25
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 25
- 229960002930 sirolimus Drugs 0.000 claims description 25
- 230000002792 vascular Effects 0.000 claims description 25
- 239000011248 coating agent Substances 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 13
- 229960001592 paclitaxel Drugs 0.000 claims description 13
- 229930012538 Paclitaxel Natural products 0.000 claims description 12
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 229920002635 polyurethane Polymers 0.000 claims description 10
- 239000004814 polyurethane Substances 0.000 claims description 10
- 239000003607 modifier Substances 0.000 claims description 7
- -1 polysiloxane Polymers 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 6
- 239000011159 matrix material Substances 0.000 claims description 6
- 230000003872 anastomosis Effects 0.000 claims description 5
- 210000004204 blood vessel Anatomy 0.000 claims description 5
- 206010020718 hyperplasia Diseases 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 3
- 210000000056 organ Anatomy 0.000 claims description 3
- 230000003878 venous anastomosis Effects 0.000 claims description 3
- 230000003881 arterial anastomosis Effects 0.000 claims description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims 6
- 239000002473 artificial blood Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims 1
- 239000005020 polyethylene terephthalate Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 description 79
- 239000000243 solution Substances 0.000 description 44
- 239000003795 chemical substances by application Substances 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000012384 transportation and delivery Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 210000003462 vein Anatomy 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 208000037803 restenosis Diseases 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 238000013268 sustained release Methods 0.000 description 6
- 239000003146 anticoagulant agent Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 239000012730 sustained-release form Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000012867 bioactive agent Substances 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 229960004676 antithrombotic agent Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000001028 anti-proliverative effect Effects 0.000 description 2
- 229940127218 antiplatelet drug Drugs 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000003684 drug solvent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004789 organ system Anatomy 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000009121 systemic therapy Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000005167 vascular cell Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 206010006440 Bronchial obstruction Diseases 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003510 anti-fibrotic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000003352 fibrogenic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000001453 nonthrombogenic effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 238000012385 systemic delivery Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/813,315 US20050220835A1 (en) | 2004-03-30 | 2004-03-30 | Agent eluting bioimplantable devices and polymer systems for their preparation |
| PCT/US2005/010835 WO2005094377A2 (en) | 2004-03-30 | 2005-03-30 | Agent eluting bioimplantable devices and polymer systems for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007531594A true JP2007531594A (ja) | 2007-11-08 |
| JP2007531594A5 JP2007531594A5 (enExample) | 2008-08-07 |
Family
ID=35054584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007506531A Pending JP2007531594A (ja) | 2004-03-30 | 2005-03-30 | 薬剤を溶出する生体埋め込み型装置及び薬剤調製ポリマーシステム |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20050220835A1 (enExample) |
| EP (1) | EP1750617A4 (enExample) |
| JP (1) | JP2007531594A (enExample) |
| AU (1) | AU2005228688A1 (enExample) |
| CA (1) | CA2561561A1 (enExample) |
| WO (1) | WO2005094377A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008296021A (ja) * | 2007-06-01 | 2008-12-11 | Taewoong Medical Co Ltd | 薬物放出ステント用コーティング剤、その製造方法、および前記コーティング剤でコートされた薬物放出ステント |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7867275B2 (en) | 1995-06-07 | 2011-01-11 | Cook Incorporated | Coated implantable medical device method |
| US7846202B2 (en) | 1995-06-07 | 2010-12-07 | Cook Incorporated | Coated implantable medical device |
| US8388677B2 (en) * | 2004-10-29 | 2013-03-05 | Boston Scientific Scimed, Inc. | Anti-thrombogenic and anti-restenotic vascular medical devices |
| WO2007041131A2 (en) * | 2005-09-30 | 2007-04-12 | Cook Incorporated | Coated vaso-occlusion device |
| US9474833B2 (en) | 2006-12-18 | 2016-10-25 | Cook Medical Technologies Llc | Stent graft with releasable therapeutic agent and soluble coating |
| US20090171453A1 (en) * | 2007-12-28 | 2009-07-02 | Adams Tara K | Drug Coated Stent Having a Surface Treatment and Method of Manufacturing |
| DE102008002471A1 (de) * | 2008-06-17 | 2009-12-24 | Biotronik Vi Patent Ag | Stent mit einer Beschichtung oder einem Grundkörper, der ein Lithiumsalz enthält, und Verwendung von Lithiumsalzen zur Restenoseprophylaxe |
| KR101034654B1 (ko) * | 2009-01-15 | 2011-05-16 | 성균관대학교산학협력단 | 바이오액티브 물질 코팅방법 |
| US8715705B2 (en) * | 2009-07-29 | 2014-05-06 | Covidien Lp | Multilayer medical devices having an encapsulated edge and methods thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56136565A (en) * | 1980-02-29 | 1981-10-24 | Thoratec Lab Corp | Polymer surface as blood contacting surface of biological medical device and its forming method |
| WO1993007217A1 (en) * | 1991-10-01 | 1993-04-15 | Otsuka Pharmaceutical Factory, Inc. | Antithrombotic resin, tube, film and coating |
| WO2004009147A1 (en) * | 2002-07-18 | 2004-01-29 | Medtronic Ave Inc. | Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US187288A (en) * | 1877-02-13 | Improvement in ratchet-wrenches | ||
| US107330A (en) * | 1870-09-13 | Improvement in car-starters | ||
| US4374669A (en) * | 1975-05-09 | 1983-02-22 | Mac Gregor David C | Cardiovascular prosthetic devices and implants with porous systems |
| US4675361A (en) * | 1980-02-29 | 1987-06-23 | Thoratec Laboratories Corp. | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
| US4861830A (en) * | 1980-02-29 | 1989-08-29 | Th. Goldschmidt Ag | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
| US4604762A (en) * | 1981-02-13 | 1986-08-12 | Thoratec Laboratories Corporation | Arterial graft prosthesis |
| US4910015A (en) * | 1987-10-19 | 1990-03-20 | Massachusetts Institute Of Technology | Surface-active polysiloxanes and drug releasing materials thereof |
| JPH02502639A (ja) * | 1987-12-23 | 1990-08-23 | ポルタフスキ メディツィンスキ ストマトロギチェスキ インスティテュト | 性病の個人予防及び尿性器トリコモナス症の治療のための医薬 |
| US4840796A (en) * | 1988-04-22 | 1989-06-20 | Dow Corning Corporation | Block copolymer matrix for transdermal drug release |
| US6515009B1 (en) * | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| PT633783E (pt) * | 1992-03-30 | 2000-11-30 | American Home Prod | Formulacao de rapamicina para injeccao intravenosa |
| GB9215002D0 (en) * | 1992-07-15 | 1992-08-26 | Univ Singapore | Method of fixing biological tissue |
| PT1118325E (pt) * | 1993-07-29 | 2006-05-31 | Us Health | Utilizacao de paclitaxel e seus derivados na preparacao de um medicamento para o tratamento de restenose |
| US5723004A (en) * | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
| US5482925A (en) * | 1994-03-17 | 1996-01-09 | Comedicus Incorporated | Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
| US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
| US5877205A (en) * | 1996-06-28 | 1999-03-02 | Board Of Regents, The University Of Texas System | Parenteral paclitaxel in a stable non-toxic formulation |
| US5962620A (en) | 1996-08-26 | 1999-10-05 | Tyndale Plains-Hunter, Ltd. | Hydrophicic and hydrophobic polyether polyurethanes and uses therefor |
| US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
| US6335029B1 (en) * | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
| WO2000048530A1 (en) * | 1999-02-16 | 2000-08-24 | Talison Research, Inc. | Multilayer and multifunction vascular graft |
| US6387116B1 (en) * | 1999-06-30 | 2002-05-14 | Pharmasonics, Inc. | Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts |
| EP1216037A2 (en) * | 1999-09-21 | 2002-06-26 | Emory University | Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| US6776796B2 (en) * | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
| DE60115712T2 (de) * | 2000-08-23 | 2006-09-07 | Thoratec Corp., Pleasanton | Beschichtete gefässtransplantate und verwendungsverfahren |
| US6545097B2 (en) | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
| US6592885B2 (en) * | 2001-06-07 | 2003-07-15 | Matthew D. Phaneuf | Method for making infection-resistant fabricated textile articles for biomedical applications |
| US20020187288A1 (en) * | 2001-06-11 | 2002-12-12 | Advanced Cardiovascular Systems, Inc. | Medical device formed of silicone-polyurethane |
| US6752826B2 (en) * | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
| EP1534355A1 (en) | 2002-06-21 | 2005-06-01 | Genzyme Corporation | Silicone blends and composites for drug delivery |
| US20040213826A1 (en) * | 2003-04-28 | 2004-10-28 | Marx Steven O. | Medical devices and methods for inhibiting proliferation of smooth muscle cells |
-
2004
- 2004-03-30 US US10/813,315 patent/US20050220835A1/en not_active Abandoned
-
2005
- 2005-03-30 AU AU2005228688A patent/AU2005228688A1/en not_active Abandoned
- 2005-03-30 WO PCT/US2005/010835 patent/WO2005094377A2/en not_active Ceased
- 2005-03-30 CA CA002561561A patent/CA2561561A1/en not_active Abandoned
- 2005-03-30 JP JP2007506531A patent/JP2007531594A/ja active Pending
- 2005-03-30 EP EP05761380A patent/EP1750617A4/en not_active Withdrawn
-
2008
- 2008-11-14 US US12/270,995 patent/US20090130170A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56136565A (en) * | 1980-02-29 | 1981-10-24 | Thoratec Lab Corp | Polymer surface as blood contacting surface of biological medical device and its forming method |
| WO1993007217A1 (en) * | 1991-10-01 | 1993-04-15 | Otsuka Pharmaceutical Factory, Inc. | Antithrombotic resin, tube, film and coating |
| WO2004009147A1 (en) * | 2002-07-18 | 2004-01-29 | Medtronic Ave Inc. | Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008296021A (ja) * | 2007-06-01 | 2008-12-11 | Taewoong Medical Co Ltd | 薬物放出ステント用コーティング剤、その製造方法、および前記コーティング剤でコートされた薬物放出ステント |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1750617A2 (en) | 2007-02-14 |
| WO2005094377A2 (en) | 2005-10-13 |
| US20090130170A1 (en) | 2009-05-21 |
| AU2005228688A1 (en) | 2005-10-13 |
| CA2561561A1 (en) | 2005-10-13 |
| EP1750617A4 (en) | 2009-08-12 |
| WO2005094377A3 (en) | 2007-03-01 |
| US20050220835A1 (en) | 2005-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6306166B1 (en) | Loading and release of water-insoluble drugs | |
| EP2134383B1 (en) | Drug coated stent with magnesium topcoat | |
| RU2316358C2 (ru) | Устройство для выдачи лекарственного средства, способ его изготовления и его применение | |
| US20050159704A1 (en) | High concentration medicament and polymer coated device for passive diffusional medicament delivery | |
| US20090130170A1 (en) | Agent eluting bioimplantable devices and polymer systems for their preparation | |
| JP2002531183A (ja) | 活性剤の制御された送達のためのポリマーコーティング | |
| US20050159809A1 (en) | Implantable medical devices for treating or preventing restenosis | |
| US20040098118A1 (en) | Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device | |
| JP2017140436A (ja) | 水不溶性治療剤と添加剤とを含むコーティングがなされた医療装置 | |
| US20060025726A1 (en) | Implantable medical device with pharmacologically active layer | |
| CN110772670A (zh) | 莫司涂层及其使用方法 | |
| US20060030826A1 (en) | Implantable medical device with anti-neoplastic drug | |
| JP2007531594A5 (enExample) | ||
| CN101496813A (zh) | 抗组织增生(血管再狭窄)组合物及应用方法 | |
| CN101467921A (zh) | 药物洗脱支架的生产方法 | |
| AU2011265436A1 (en) | Agent eluting bioimplantable devices and polymer systems for their preparation | |
| JP2022519171A (ja) | 局所薬剤送達のためのカバードステント | |
| KR20090098535A (ko) | 혈관 재협착의 예방 또는 치료용 조성물 | |
| HK1150229A1 (en) | Drug-delivery endovascular stent and method for treating restenosis | |
| HK1150229B (en) | Drug-delivery endovascular stent and method for treating restenosis | |
| HK1146910A (en) | Medical device for dispensing medicaments | |
| KR20140115542A (ko) | 혈관 재협착의 예방 또는 치료용 약물 전달 시스템 | |
| HK1114798B (en) | Balloon catheter for dispensing medicaments, the preparation and the use thereof | |
| HK1139879B (en) | Improved pharmaceutical-coated medical products and the production thereof | |
| HK1116100B (en) | Medical device for dispensing medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080329 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080329 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080618 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110329 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110629 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111227 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120323 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120330 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120911 |